Combination Chemotherapy in Treating Patients With Bladder Cancer
Genitourinary Cancer
-
-
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
-
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
-
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
-
Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
-
AFT Study Finds Some Prostate Cancer Drugs Related to More Cognitive Decline
A new randomized Alliance Foundation Trials (AFT) clinical study found that men with advanced prostate cancer taking the hormone therapy medication darolutamide had less cognitive decline compared to men taking enzalutamide. According to results from the ARACOG (AFT-47) phase II trial, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2026,…
-
Highlighting Alliance Progress and Impact in Research through News Reports
Highlighting Alliance Progress and Impact in Research through News Reports At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the…
Categories
Alliance Committee
Browse by Year